NanoCell Ltd. is dedicated to advancing women’s reproductive health through biopharmaceutical technologies that significantly improve embryo implantation, consequently increasing the chances of conceiving. Through an inter-disciplinarian approach we take a scientific discovery to develop a proprietary intrauterine treatment resulting in improved embryo implantation rates.

NanoCell is developing a method, a kit and a composition for improving the implantation rate of embryos for both human and livestock. More specifically, the method and composition will be indicated for improving the efficiency of embryo implantation by using enzymatically remodeled extra-cellular matrix (ECM).